# Reproductive Medicine Institute – FDA Inspection, Jun 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/cad92f77-b2be-448c-9168-4f11ca6dfe8f
Source feed: FDA_Inspections

> FDA inspection 1321232 of Reproductive Medicine Institute, June 09, 2026. 1 citation under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321232
- Company Name: Reproductive Medicine Institute
- Inspection Date: 2026-06-09
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Chicago District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1216427 - 2023-08-21
- FDA Inspection 1057831 - 2018-06-19
- FDA Inspection 969650 - 2016-05-12
- FDA Inspection 879502 - 2014-05-19
- FDA Inspection 754960 - 2011-11-29

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-a-moore/361e4fe8-caf0-4320-963a-3838616850e2)
- [FDA Personnel](https://www.keypedia.com/people/zoey-a-trombley/cb7ac4dd-bc47-4b51-8fef-a485b122c921)

Company: https://www.keypedia.com/companies/reproductive-medicine-institute/b3a4469f-9346-4e8b-81c0-b256c28b3031

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669